Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study
Andrii R Korol,1 Oleksandra Zborovska,2 Taras Kustryn,1 Oleksandra Dorokhova,2 Nataliya Pasyechnikova3 1Laser Department, 2Department of Inflammatory Pathology of the Eye, 3Filatov Institute of Eye Diseases and Tissue Therapy, National Academy of Medical Sciences of Ukraine, Odess...
Guardado en:
Autores principales: | Korol AR, Zborovska O, Kustryn T, Dorokhova O, Pasyechnikova N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bc733aecadca4690bf5eb8910fdd6d2a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intravitreal aflibercept for the treatment of choroidal neovascularization associated with pathologic myopia: a pilot study
por: Korol AR, et al.
Publicado: (2016) -
Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
por: Korol AR, et al.
Publicado: (2017) -
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
por: Jia-Kang Wang, et al.
Publicado: (2018) -
Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration
por: Balaratnasingam C, et al.
Publicado: (2015) -
Recognition, Diagnosis and Treatment of Chorioretinal Folds: Current Perspectives
por: Grosso D, et al.
Publicado: (2020)